Transesophageal echocardiography for thrombus screening prior to left atrial catheter ablation

Circulation Journal

Volumn 74, Issue 6, 2010, Pages 1081-1086

  Yamashita, Eiji ^a   Takamatsu, Hiroto ^b   Tada, Hiroshi ^c   Toide, Hiroyuki ^a   Okaniwa, Hiroki ^a   Takemura, Naoki ^a   Sasaki, Takehito ^a   Miki, Yuko ^a   Fuke, Etsuko ^a   Hayashi, Tatsuya ^a   Sakamoto, Tamotsu ^a   Nakamura, Koki ^a   Fukazawa, Rie ^a   Sato, Chizuru ^a   Goto, Koji ^a   Kaseno, Kenichi ^a   Kumagai, Koji ^a   Naito, Shigeto ^a   Hoshizaki, Hiroshi ^a   Oshima, Shigeru ^a  

^a GUNMA PREFECTURAL CARDIOVASCULAR CENTER   (Japan)

^b Fujioka General Hospital   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Atrial fibrillation; Catheter ablation; Thrombus; Transesophageal echocardiography

Indexed keywords

ADULT; AGED; AORTA STENOSIS; ARTICLE; CARDIOMYOPATHY; CATHETER ABLATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART INFARCTION; HEART LEFT ATRIUM; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; SCORING SYSTEM; SCREENING; THROMBOEMBOLISM; THROMBUS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGE FACTORS; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART ATRIA; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK FACTORS; THROMBOSIS;

EID: 77953514793     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-1002     Document Type: Article

References (23)

1. Ouyang F, Bansch D, Ernst S, Schaumann A, Hachiya H, Chen M, et al. Complete isolation of left atrium surrounding the pulmonary veins: New insights from the double-Lasso technique in paroxysmal atrial fibrillation. Circulation 2004; 110: 2090-2096.
2. Oral H, Chugh A, Good E, Igic P, Elmouchi D, Tschopp DR, et al. Randomized comparison of encircling and nonencircling left atrial ablation for chronic atrial fibrillation. Heart Rhythm 2005; 2: 1165-1172.
3. Tada H, Kurosaki K, Ito S, Naito S, Yamada M, Miyaji K, et al. Left atrial and pulmonary vein ostial ablation as a new treatment for curing persistent atrial fibrillation. Circ J 2005; 69: 1057-1063.
4. Ogawa S, Yamashita T, Yamazaki T, Aizawa Y, Atarashi H, Inoue H, et al. Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study. Circ J 2009; 73: 242-248.
5. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, et al. Risk of thromboembolic events after percutaneous left atrial radio-frequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765.
6. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105.
7. Calkins H, Brugada J, Packer DL, Cappato R, Chen SA, Crijns HJ, et al. HRS/EHRA/ECAS expert Consensus Statement on catheter and surgical ablation of atrial fibrillation: Recommendations for personnel, policy, procedures and follow-up: A report of the Heart Rhythm Society (HRS) Task Force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm 2007; 4: 816-861.
8. Manning WJ, Weintraub RM, Waksmonski CA, Haering JM, Rooney PS, Maslow AD, et al. Accuracy of transesophageal echo-cardiography for identifying left atrial thrombi: A prospective, intra-operative study. Ann Intern Med 1995; 123: 817-822.
9. Fatkin D, Scalia G, Jacobs N, Burstow D, Leung D, Walsh W, et al. Accuracy of biplane transesophageal echocardiography in detecting left atrial thrombus. Am J Cardiol 1996; 77: 321-323.
10. Natale A, Raviele A, Arentz T, Calkins H, Chen SA, Haissaguerre M, et al. Venice Chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007; 18: 560-580.
11. Scherr D, Dalal D, Chilukuri K, Dong J, Spragg D, Henrikson CA, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20: 379-384.
12. JCS 2008 Guidelines for Pharmacotherapy of Atrial Fibrillation. Circ J 2008; 72(Suppl): 1581-1638.
13. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870.
14. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
15. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-133.
16. Feng D, Syed IS, Martinez M, Oh JK, Jaffe AS, Grogan M, et al. Intracardiac thrombosis and anticoagulation therapy in cardiac amy-loidosis. Circulation 2009; 119: 2490-2497.
17. Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K. Mechanism of atrial fibrillation and increased incidence of thromboembolism in patients with hypertrophic cardiomyopathy. Jpn Circ J 1995; 59: 329-336.
18. Lombardo RM, Reina C, Abrignani MG, Braschi A, De Castro S. Embolic stroke, sinus rhythm and left atrial mechanical function. Eur J Echocardiogr 2006; 7: 401-404.
19. Suzuki S, Yamashita T, Kato T, Fujino T, Sagara K, Sawada H, et al. Incidence of major bleeding complication of warfarin therapy in Japanese patients with atrial fibrillation. Circ J 2007; 71: 761-765.
20. Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: A multicenter, prospective, randomized trial: Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke 2000; 31: 817-821.
21. Yasaka M, Minematsu K, Yamaguchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 2001; 40: 1183-1188.
22. Furusho H, Takamura M, Takata S, Sakagami S, Hirazawa M, Kato T, et al. Current status of anticoagulation therapy for elderly atrial fibrillation patients in Japan: From Hokuriku atrial fibrillation trial. Circ J 2008; 72: 2058-2061.
23. Knecht S, Wright M, Lellouche N, Nault I, Matsuo S, O'Neill MD, et al. Impact of a patent foramen ovale on paroxysmal atrial fibrillation ablation. J Cardiovasc Electrophysiol 2008; 19: 1236-1241.